FitLife Brands Research and Development Expenses 2012-2026 | FTLF
FitLife Brands research and development expenses from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
|
FitLife Brands Annual Research and Development Expenses (Millions of US $) |
|---|
|
FitLife Brands Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2011-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.088B | $0.081B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.555B | 19.51 |
| Medtronic (MDT) | Ireland | $117.847B | 16.11 |
| Stryker (SYK) | United States | $105.529B | 19.72 |
| EssilorLuxottica (ESLOY) | France | $73.880B | 0.00 |
| Boston Scientific (BSX) | United States | $62.810B | 13.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.597B | 0.00 |
| Agilent Technologies (A) | United States | $44.113B | 25.82 |
| Medline (MDLN) | United States | $41.597B | 0.00 |
| ResMed (RMD) | United States | $32.455B | 20.14 |
| GE HealthCare Technologies (GEHC) | United States | $28.967B | 13.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $20.887B | 19.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.189B | 11.24 |
| Baxter (BAX) | United States | $11.788B | 11.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.573B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.065B | 40.56 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.563B | 20.19 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.024B | 0.00 |
| BillionToOne (BLLN) | United States | $4.998B | 151.31 |
| Haemonetics (HAE) | United States | $4.932B | 21.64 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.815B | 22.78 |
| Envista Holdings (NVST) | United States | $3.750B | 15.88 |
| AtriCure (ATRC) | United States | $2.955B | 252.61 |
| Neogen (NEOG) | United States | $2.835B | 50.00 |
| Curaleaf Holdings (CURLF) | United States | $2.445B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.265B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.132B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.130B | 10.17 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.810B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.804B | 29.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.795B | 229.31 |
| Kestra Medical Technologies (KMTS) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.426B | 15.21 |
| Phibro Animal Health (PAHC) | United States | $1.403B | 10.77 |
| Omeros (OMER) | United States | $1.294B | 6.55 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.065B | 0.00 |
| CeriBell (CBLL) | United States | $0.935B | 0.00 |
| InMode (INMD) | Israel | $0.825B | 11.48 |
| AdaptHealth (AHCO) | United States | $0.779B | 16.31 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.12 |
| Glass House Brands (GLAS) | United States | $0.748B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.728B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.553B | 0.00 |
| Brainsway (BWAY) | Israel | $0.547B | 30.93 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Cerus (CERS) | United States | $0.534B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.527B | 0.00 |
| Evolus (EOLS) | United States | $0.519B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.443B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.339B | 24.75 |
| Sanara MedTech (SMTI) | United States | $0.322B | 159.41 |
| TriSalus Life Sciences (TLSI) | United States | $0.314B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.279B | 0.00 |
| MacroGenics (MGNX) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 13.35 |
| OraSure Technologies (OSUR) | United States | $0.246B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 22.55 |
| High Tide (HITI) | Canada | $0.230B | 51.60 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.202B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.197B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.148B | 0.00 |
| Quanterix (QTRX) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.090B | 124.38 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.068B | 3.87 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 4.00 |
| Nephros (NEPH) | United States | $0.047B | 39.18 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.039B | 18.96 |
| United-Guardian (UG) | United States | $0.033B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |